Afya (AFYA) Research & Development (2017 - 2019)

Afya has disclosed Research & Development across 3 years of filings, most recently posting -$2.8 million for Q4 2019.

• In Q4 2019, Research & Development changed N/A year-over-year to -$2.8 million; the TTM figure through Dec 2019 stood at -$2.8 million (changed N/A YoY), while the FY2019 annual figure was -$2.9 million, changed N/A from the prior year.
• Research & Development came in at -$2.8 million for Q4 2019 at Afya, down from $564777.4 in the prior quarter.
• In the past five years, Research & Development ranged from a high of $564777.4 in Q3 2019 to a low of -$2.8 million in Q4 2019.
• Average Research & Development over 3 years is -$690863.3, with a median of -$254114.2 recorded in 2017.
• The largest YoY upside for Research & Development was 262.33% in 2019 against a maximum downside of 262.33% in 2019.
• Over 3 years, Research & Development stood at -$664104.1 in 2017, then surged by 123.47% to $155875.7 in 2018, then tumbled by 1909.13% to -$2.8 million in 2019.
• Per Business Quant data, the three most recent Research & Development figures were -$2.8 million in Q4 2019, $564777.4 in Q3 2019, and $155875.7 in Q3 2018.